Wide Ranks

MDXH

MDxHealth SA

1.96

Top Statistics
Market Cap 97 M Forward PE -3.92 Revenue Growth 20.50 %
Current Ratio 1.54 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -49.52 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -3.03 Enterprise / Revenue 0.7190 Price To Sales Trailing12 Months 1.15
Profitability
Profit Margins -49.52 % Operating Margins -26.13 %
Balance Sheet
Total Cash 49 M Total Cash Per Share 1.76 Total Debt 55 M
Total Debt To Equity 325.62 Current Ratio 1.54 Book Value Per Share 0.6080
All Measures
Short Ratio 15.00 % Message Board Id finmb_4803148 Shares Short Prior Month 29361
Return On Equity -2.41 City Herstal Uuid e97b45b6-9430-3bb3-a498-f3ee26ac6d63
Previous Close 1.94 First Trade Date Epoch Utc 1 B Book Value 0.6080
Beta -393982.88 Total Debt 55 M Volume 88697
Price To Book 3.22 Fifty Two Week Low 1.55 Total Cash Per Share 1.76
Total Revenue 84 M Shares Short Previous Month Date 1 B Target Median Price 6.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -26.13 %
Target Mean Price 6.04 Net Income To Common -41948000 Short Percent Of Float 0.0004
Implied Shares Outstanding 49 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 264430 Average Volume10days 264430 Total Cash 49 M
Next Fiscal Year End 1 B Revenue Per Share 3.10 Held Percent Insiders 0.1222
Ebitda Margins -23.74 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.94 Target Low Price 4.20
Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.02 Open 1.94
Free Cashflow 5 M Dividend Yield 0.00 % Return On Assets -0.1101
Time Zone Short Name EST Trailing Eps -1.53 Day Low 1.85
Address1 CAP Business Center Shares Outstanding 49 M Price Hint 4
Target High Price 7.00 Website https://mdxhealth.com 52 Week Change -0.3932
Average Volume 133787 Forward Eps -0.5700 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 141.10 % Is_sp_500 False
Regular Market Day High 1.98 Profit Margins -49.52 % Debt To Equity 325.62
Fifty Two Week High 4.64 Day High 1.98 Shares Short 16217
Regular Market Open 1.94 Industry Key diagnostics-research Earnings Growth 0.00 %
Enterprise To Revenue 0.7190 Revenue Growth 20.50 % Shares Percent Shares Out 0.0003
Operating Cashflow -22786000 Currency USD Time Zone Full Name America/New_York
Market Cap 97 M Is_nasdaq_100 False Zip 4040
Quote Type EQUITY Industry Diagnostics & Research Long Name MDxHealth SA
Regular Market Day Low 1.85 Held Percent Institutions 0.4866 Current Price 1.96
Address2 Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts Enterprise To Ebitda -3.03 Financial Currency USD
Current Ratio 1.54 Gross Margins 61.74 % Industry Disp Diagnostics & Research
Number Of Analyst Opinions 5 Country Belgium Float Shares 22 M
Two Hundred Day Average 2.61 Enterprise Value 60 M Price To Sales Trailing12 Months 1.15
Forward PE -3.92 Regular Market Volume 88697 Ebitda -20112000
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.

The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment.

It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers.

The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010.

MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.